                         SEQUENCE LISTING

<110>  THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND 
       AGRICULTURAL AND MECHANICAL COLLEGE
 
<120>  COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT

<130>  222227-2020

<150>  US 61/897344
<151>  2013-10-30

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Scramble oligo

<400>  1
agcctcgagt acctatacta c                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>   Gbeta1 shRNA (NM_008142.4)

<400>  2
ccacatttac tggacacact g                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ggamma2 shRNA  (NM_010315.4)

<400>  3
gccaacatcg acaggataaa g                                                 21


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Galphai Scramble shRNA

<400>  4
gaccaatacg tacagacgga                                                   20


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Galphai1 shRNA

<400>  5
gaggagtgta agcagtacaa g                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Galphai2

<400>  6
aatgatcgac aagaacctgc g                                                 21


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Galphai3

<400>  7
ctagcaggcg tgattaaacg t                                                 21


<210>  8
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer sequence for Galphai1 shRNA resistant construct

<400>  8
gggctagcgc caccatgggc tgcacattga gcgctg                                 36


<210>  9
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Galphai1 shRNA

<400>  9
cttatattgt ttgcactcct cttccgagta gccggcttcg tgg                         43


<210>  10
<211>  43
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer sequence for Galphai1 shRNA resistant construct

<400>  10
gaggagtgca aacaatataa ggcagtggtc tacagcaaca cta                         43


<210>  11
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer sequence for Galphai1 shRNA resistant construct

<400>  11
gggaccggtg aagagaccac agtcttttag                                        30


<210>  12
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer for the Gbeta2 shRNA resistant construct

<400>  12
gggctagcgc caccatgagt gaacttgacc agctg                                  35


<210>  13
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer for the Gbeta2 shRNA resistant construct

<400>  13
cagtatgccc ggtgaatgtg gttgtctgct ggccagtctc ga                          42


<210>  14
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer for the Gbeta2 shRNA resistant construct

<400>  14
ccacattcac cgggcatact ggagatgtca tgagcctgtc tc                          42


<210>  15
<211>  31
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer for the GBeta2 shRNA resistant construct

<400>  15
gggaccggtg ttccagatct tgaggaagct g                                      31


<210>  16
<211>  225
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  16
ctagcgccac catggccagc aacaacaccg ccagcatagc acaagccagg aagctggtag       60

aacagctgaa gatggaagcc aatatagata gaataaaggt gtccaaggca gctgctgact      120

tgatggccta ctgtgaggca catgccaagg aagaccctct gctgacccca gtcccagcct      180

cagaaaaccc ctttcgggag aagaagttct tctgcgccat cctta                      225


<210>  17
<211>  225
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  17
ccggtaagga tggcgcagaa gaacttcttc tcccgaaagg ggttttctga ggctgggact       60

ggggtcagca gagggtcttc cttggcatgt gcctcacagt aggccatcaa gtcagcagct      120

gccttggaca cctttattct atctatattg gcttccatct tcagctgttc taccagcttc      180

ctggcttgtg ctatgctggc ggtgttgttg ctggccatgg tggcg                      225


<210>  18
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  COX-2 forward primer

<400>  18
aagcgaggac ctgggttcac                                                   20


<210>  19
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  COX-2 reverse primer

<400>  19
acacctctcc accaatgacc tg                                                22


<210>  20
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>   Beta1 forward primer

<400>  20
gacctactcc catgacaaca tt                                                22


<210>  21
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Beta1 reverse primer

<400>  21
tgagtgcatc ccagacatta c                                                 21


<210>  22
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  gamma2 forward primer

<400>  22
agccaacatc gacaggataa a                                                 21


<210>  23
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  gamma 2 reverse primer

<400>  23
taaaggatgg cgcagaagaa                                                   20


<210>  24
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NM_010315.4; GAPDH forward primer

<400>  24
accacagtcc atgccatcac                                                   20


<210>  25
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GAPDH reverse primer

<400>  25
ccttgcccac agccttg                                                      17


<210>  26
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NF-kappaB binding site forward primer

<400>  26
ctgtgtgcgt gctctga                                                      17


<210>  27
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NF-kappaB binding site reverse primer

<400>  27
tcaagagtgt cacagcttcc                                                   20


